Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Other Accumulated Expenses: 2020-2022

Historic Other Accumulated Expenses for CureVac N.V (CVAC) over the last 3 years, with Dec 2022 value amounting to $41.3 million.

  • CureVac N.V's Other Accumulated Expenses rose 11739.93% to $41.3 million in Q4 2022 from the same period last year, while for Dec 2022 it was $41.3 million, marking a year-over-year increase of 11739.93%. This contributed to the annual value of $41.3 million for FY2022, which is 11739.93% up from last year.
  • CureVac N.V's Other Accumulated Expenses amounted to $41.3 million in FY2022, which was up 11,739.93% from $348,911 recorded in FY2021.
  • CureVac N.V's 5-year Other Accumulated Expenses high stood at $41.3 million for FY2022, and its period low was $348,911 during FY2021.
  • In the last 3 years, CureVac N.V's Other Accumulated Expenses had a median value of $2.4 million in 2020 and averaged $14.7 million.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first plummeted by 85.63% in 2021, then soared by 11,739.93% in 2022.
  • Over the past 3 years, CureVac N.V's Other Accumulated Expenses (Yearly) stood at $2.4 million in 2020, then tumbled by 85.63% to $348,911 in 2021, then soared by 11,739.93% to $41.3 million in 2022.